Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMOylation of EphB4 enhances its stability in prostate cancer. | Br J Cancer | 2026 | 41986660 | PubTator, text mining | PubMed |
| Chinese capillary malformation-arteriovenous malformation: clinical and genetic analysis of eight cases. | Front Med (Lausanne) | 2026 | 41970387 | PubTator, text mining | PubMed |
| EphB4-decorated biomimetic nanoparticles enhance osteoclast targeting and therapeutic effect in osteoporosis. | J Nanobiotechnology | 2026 | 41957808 | PubTator, text mining | PubMed |
| Enhancing Inhibitory Potency and Serum Stability of Peptide Inhibitors of the EphB2 Receptor. | Biochemistry | 2026 | 41930744 | PubTator, text mining | PubMed |
| Tumor exosomes impact functional hallmarks of cancer. | Cancer Metastasis Rev | 2026 | 41912733 | PubTator, text mining | PubMed |
| Eph receptors in pancreatic cancer: Biological roles and clinical implications. | Crit Rev Oncol Hematol | 2026 | 41903913 | PubTator, text mining | PubMed |
| LIPUS as a potential strategy for anti-inflammation and repair: A review of the mechanisms. | Int J Med Sci | 2026 | 41799780 | PubTator, text mining | PubMed |
| Transcriptional coordination in multicellular lineage differentiation during lung organogenesis: deciphering the role of epithelial cells as a microenvironmental regulatory hub. | Front Cell Dev Biol | 2026 | 41799436 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Vein of Galen Malformation with Pial Arteriovenous Fistula in a 12-month-old Child. | Asian J Neurosurg | 2026 | 41782586 | PubTator, text mining | PubMed |
| Breast tumour-secreted ADAM10 mediates atrial fibrogenesis and fibrillation. | Eur Heart J | 2026 | 41780910 | PubTator, text mining | PubMed |
The enhanced osteogenic differentiation of human periodontal ligament stem cells and M2 polarization of macrophages may be mediated by EphB4/ephrinB2 signaling pathway: a study of their direct co-culture. | Stem Cell Res Ther | 2026 | 41772692 | PubTator, text mining | PubMed |
| CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. | Cancer Metastasis Rev | 2026 | 41770377 | PubTator, text mining | PubMed |
| Multifunctional implantable hydrogels: Smart platforms at the forefront of biomedical innovation. | Mater Today Bio | 2026 | 41769378 | PubTator, text mining | PubMed |
| Clinical, Prognostic, and Biological Features of High-Risk Cardiometabolic Phenotype: The REMODEL Study. | MedComm (2020) | 2026 | 41768368 | PubTator, text mining | PubMed |
| Pathophysiology of androgen-associated endothelial cell dysfunction in phenotype A polycystic ovarian syndrome revealed by iPSCs modeling. | Front Endocrinol (Lausanne) | 2026 | 41767389 | PubTator, text mining | PubMed |
| Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. | Ann Med | 2026 | 41741334 | PubTator, text mining | PubMed |
| GelMA-Based Nanocomposites for Bone Defect Regeneration: Design, Performance, and Clinical Translation Potential. | Int J Nanomedicine | 2026 | 41737038 | PubTator, text mining | PubMed |
| Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer. | J Adv Res | 2026 | 41730417 | PubTator, text mining | PubMed |
| Identification of ephrin-A1-EphA2 signalling as a potential target for fracture prevention. | Nat Commun | 2026 | 41723149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=2